BMRA vs MELI · rev $4.5M vs P/E 43, rev $19.01B
Biomerica Inc (BMRA) versus MercadoLibre Inc. (MELI) — a side-by-side from cached financials, not a winner call.
Biomerica Inc (BMRA) is a medical devices company listed on US.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Latest reported BMRA revenue for 2026-05-31 was $4.5M. Net income was -$3.8M. Revenue was down 16.2% from 2025-05-31 to 2026-05-31. BMRA currently screens at market cap $8.0M.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
BMRA currently screens at market cap $8.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Not investment advice. Open the BMRA and MELI stock pages for the full models.
Not investment advice.